1Gebhard JR;Zhu J;Cao X;etal.DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes[J],2000(17). 被引量：1
3Syed TA;Cheema KM;Kahlon BM.Human leukocyte interferon-alpha in cream for the treatment of genital herpes in Asian male A placebocontrolled,1995. 被引量：1
4Syed TA;Lundin S;Cheema KM.Human leukocyte interferon alpha in cream for the management of genital herpes in Asian women:aplacebo-controlled double-blind study,1995(03). 被引量：1
5Safrin S;Kemmerly S;Plotkin B;etal.Foscarmetresistant herpes simplex virus infection in patients with AIDS,1994(01). 被引量：1
6CIRELLI R;Herne K;McCrary M.Famciclovir:review of clinical efficacy and safety[J],1996(2-3). 被引量：1
8Mertz G J;Loveless MO;Levin M J.Oral Famciclorir for suppression of recurrent genital herpes simplex virus infection in women,1997(03). 被引量：1
9Diaz MF;Sibbald RG;Sharfran SD.Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial Collaborative Famcicovir Genital Herpes Research Group[J],1998(10). 被引量：1
10Corey L;Langenberg AG;Ashley R.Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials Chiron HSV Vaccine Study Group[J],1999(4). 被引量：1
